Full sequence analysis and characterization of the South Korean Norovirus GII-4 variant CUK-3
© Park et al; licensee BioMed Central Ltd. 2011
Received: 28 October 2010
Accepted: 14 April 2011
Published: 14 April 2011
Many of researchers have focused on the emerging pathogen, Norovirus, since its first identification as the causing agent of nonbacterial acute gastroenteritis in humans. One of the virulence factors of norovirus, the great genetic diversity attributed to point mutations and recombinations, has brought forth the result of significant changes in the circulating norovirus genotype patterns.
In recognition of the necessity for tracking and monitoring of genetic diversity, a norovirus variant among the most prevalent genotype GII-4, Norovirus Hu/GII-4/CUK-3/2008/KR (CUK-3), was isolated from stool samples and analyzed on the level of whole genome sequence. Whole genome sequence analysis revealed three ORF composites of the whole genome, ORF1 (5100 bp), ORF2 (1623 bp), and ORF3 (807 bp). Each genetic relationship of CUK-3 variant analysis located the ORF1 (5,100 bp) in Cluster I, ORF2 (1623 bp) in Cluster I (2006b), ORF3 (807 bp) in Cluster I, and the whole genome sequence (about 5.1 kb) in Cluster I in the phylogenetic tree. And the phylogenetic analyses showed the same location of CUK-3 strain with the GII-4/2006b cluster in the phylogenetic tree.
In This study, a first concerning the full-length sequence of a NoV variant in South Korea is meaningful in that it can be used not only as a full-length NoV variant sequence standard for future comparison studies, but also as useful material for the public health field by enabling the diagnosis, vaccine development, and prediction of new emerging variants.
Noroviruses (NoVs) are the most important viruses that cause nonbacterial acute gastroenteritis in humans. In addition to increased susceptibility, the elderly are at increased risk for more severe disease and death, as are the very young and the immunocompromised [1, 2]. They are small, and non-enveloped viruses which and belong to the family Caliciviridae, genus Norovirus. Noroviruses have a single positive-strand NoV RNA genome of about 7.6 kb in size. Three open reading frames (ORFs) have been identified in the NoV genomes. ORF1 encodes a polyprotein that is cleaved into six non-structural (NS) proteins, which carry amino acid sequence motifs conserved in NTPase, protease and RNA-dependent RNA polymerase (RdRp) [3, 4]. ORF2 encodes a major structural protein, Viral Protein (VP1), which consist of two domains-the shell domain (S) and the protruding arm (P) that is again divided into two subdomains, P1 and P2. The S domain is highly conserved while the P domain is variable. P2 of the P domain is hypervariable and carries immune and cellular recognition sites [5–7]. ORF3 encodes minor capsid protein, VP2, which is rich in basic amino acids and is proposed to have a role in viral stability [8, 9]
Recently, NoVs were recognized as novel emergent pathogens. The main route of transmission is suspected to be person-to-person, but food and water-borne transmission is also important [1, 10, 11]. According to nucleotide sequence analysis of the capsid regions, noroviruses are classified into five genogroups, GI to GV, each of which can be further divided into several clusters or genotypes . Among the five genogroups, three genogroups (GI, GII and GIV) are known to cause clinical illness in humans, and genotype GII-4 has been the predominant circulating strain to the present . The error-prone RNA replication and recombination between viruses is what drives noroviruses to its the great diversity. Furthermore, the accumulated mutations of the hypervariable P2 domain of the VP1 protein produced different GII-4 NoVs . The most representative of the resulting variant GII-4 strain, GII-4/2006b, with 3 nucleotide insertions in the P2 domain at position 6265, emerged in the summer of 2002 which lead to a major gastroenteritis outbreak as well as an epidemic gastroenteritis worldwide in the winter of 2002/2003 [15, 16]. In South Korea, gastroenteritis outbreaks by GII-4/2006b variants have been reported from September of 2007 to July of 2008 had been reported .
In this paper, the whole genome sequence of another isolated variant of the emerging strain type, the GII-4 variant, was analyzed and compared with other variants to reveal the genetic relationship and to predict the tendency of GII-4 variants in South Korea.
NoV positive-stool sample was isolated from patients with acute gastroenteritis in Daejeon, South Korea in November 2008. The sample was obtained from the Waterborne Virus Bank (Seoul, Korea). The stool sample was stored at -70°. The viral genomic RNA was extracted from 140 μl of 10% fecal suspension with the QIAamp® Viral RNA Mini kit (Qiagen, Hilden, Germany) in accordance with the manufacturer's instructions.
Primer sets used in this study
Sequence (5'→ 3')
Diagnosis primer sets
CTG CCC GAA TTY GTA AAT GAT GAT
CCA ACC CAR CCA TTR TAC ATY TG
GGG AGG GCG ATC GCA ATC T
CCR CCI GCA TRI CCR TTR TAC AT
Designed primer sets
GTG AAT GAA GAT GGC GTC TAA C
AGT TCC ACT GCA AGG TCC TCA G
CTG AGG ACC TTG CAG TGG AAC T
ATG AGG GAA CCA GTG GTG AGA GT
CGT GCT CGA GGC GCA TCG ATT T
TTG TAC TCA TCA TAC TCT TCA
CAT TGC TCG AGC ATC AGG GCT AC
TTG ACT ATC CTC GAC CAG ATG CT
AGC ATC TGG TCG AGG ATA GTC AA
GTG GCA CAT ATG ACA GTG TTT CC
GGA AAC ACT GTC ATA TGT GCC AC
CAG TCG TTC TTC CGC ATG TGG TGC GG
CTC AGC ACC AAG ACT AAA TTC TGG A
TGG GCG ATG GAA TTC CAT TGA GAG G
ATG GTT AAA TTC TCC CCA GAA CC
CCA CCT GCA TAA CCA TTG TAC AT
ATG AAG ATG GCG TCG AAT GGC
TTA TAA TGC ACG CCT GCG CCC CGT
ATG GCT GGA GCT TTC TTT GCT
AAA GAC ACT AAA GAA AGG AAA GAT
To analyze the whole genome sequence of the detected norovirus strain, reverse transcription PCR (RT-PCR) was performed with the One Step RT-PCR kit (Qiagen, Hilden, Germany) with 10 pairs of newly designed primer sets (Table 1). Ten fragments were amplified; eight fragments for ORF1, one fragment for ORF2, and one fragment for ORF3. The PCR products were then analyzed by electrophoresis on 1.5% agarose gel and ethidium bromide staining. The amplified fragments were purified with HiYield™ Gel/PCR DNA Extraction kit (RBC, Taipei, Taiwan) from the gel. Then, the products were cloned into the pGEM-T Easy vector (Promega, USA) and were sequenced by Genotech (Daejeon, South Korea).
Sequence data analysis of the composite sequence of ten plasmids aligned with Clustal W method using the DNAStar software (DNAStar Inc.) revealed that the whole genome was composed of three ORFs, 5100 bp (ORF1), 1623 bp (ORF2), and 807 bp (ORF3).
The dendrograms were constructed with the neighbor-joining method. The nucleotide sequence data reported in this study have been deposited into GenBank (accession number; FJ514242).
Nucleotide and amino acid sequence similarities between CUK-3 strain and the full length ORF2 sequences from different Genogroup GII reference strains.
As shown on the case analysis of ORF1, Cluster I contains Hiroshoma1, Kumamoto1, Saga1, Hokkaodo1, Aomori4, Miayagi5, Akita1, Aichi3 and showed the highest similarity range (98.0~98.9%) (Figure 1A).
As shown on the case analysis of ORF2, Cluster I (2006b) contains emerged the GII-4 varints in Japan and showed the highest similarity range (97.7 - 99.0%), whereas Cluster II (2006a) showed low similarity range (91.7 - 92.3%) (Figure 1B).
As shown on the case analysis of ORF3, Cluster I showed the highest similarity range (97.9 - 99.3%). Interestingly, 02/03 group contains emerged the GII-4 vaiants in Europe showed more higher similarity range (93.1 - 93.6%) than Cluster II contains emerged the GII-4 variants in Japan (Figure 1C).
As shown on the case analysis of full length, the CUK-3 strain showed the highest similarity (98.3%) with the 2006 epidemic strain, Aichi3/2006/JP strain, whereas Ehime/5-30/2005/JP strain and Lordsdale/1993/UK strain showed the lowest similarity (89.2%) (Figure 1D).
The CUK-3 strain can be placed on the same branch of the phylogenetic tree as the GII-4/2006b cluster, based on the nucleotide sequence of the RdRp region and the amino acid sequence of the capsid protein (data not shown). Also, the analysis of the GDD motif (AANNTG) of the RdRp region of the GII-4 variants reported worldwide indicated that the GDD motif of CUK-3 strain was similar to that of the GII-4 variants of the epidemic strains in 2006. These strains were common in Hong Kong, Japan, and other regions of North East Asia during the same period [12, 18]. Such similarities in analyses between CUK-3 and GII-4/2006b strain are evidence of the reemergence of GII-4 variant.
Amino acid sequences of the capsid region encoded by ORF2 was compared with a total of 39 GII-4 variants reported from various countries including US, UK, Japan, China, Germany etc. Date of 540 amino acid analyses showed the pattern of changes of two amino acid in first P1 domain, aa238 (S GII-4- >2002 → T GII-4- <2002), aa250 (Y GII-4- >2002 → F GII-4- <2002). The P2 domain showed five substitutions of amino acids, aa280 (A GII-4- >2002 → P GII-4- <2002), aa346 (A GII-4- >2002 → P GII-4- <2002), aa367 (F GII-4- >1995 → Y GII-4- >2002 → F GII-4- <2002), aa376 (Q GII-4- >2002 → E GII-4- <2002), and aa394 (G or S GII-4- >2006→ TGII-4- <2006). In addition, the second P1 domain also showed two amino acid substitutions, aa459 (L GII-4- >1995 → Q GII-4- >2002) and aa504 (P GII-4- >2002 → Q GII-4- <2002). These analytic data showed that there had already been numerous mutations, which lead to the production of a wide range of variants, already before 2002 and produced various variants. And as shown on the case of aa394 of P2 domain which inserted novel amino acid, G or S, and then substituted to T after 2006 (data not shown). Although previous studies have indicated that the sequence for the NoV capsid region is useful for the diagnosis of NoV variants, no studies have analyzed the RdRp region of the South Korean NoV GII-4 variant. This is the first report that describes the full-length sequence of a NoV GII-4 variant that was isolated from clinical samples in South Korea. We suggest that this sequence can be used as a standard for the comparison of full-length NoV GII-4 variant sequence with other strains.
The information acquired from whole genome sequencing in this study can be useful not only for a more accurate diagnoses of NoVs but also for the basic research for the elucidation genetic functions. Furthermore, it will be helpful for the prediction of newly appearing pandemic variants through comparison with GII-4 variants in neighboring countries, fundamental research for vaccine development, and eventually , for the field of public health through with the provision of new emerging strains of NoV.
This work was supported by Mid-career Researcher Program (2008-0061575) and Basic Science Research Program (2009-0062720) through NRF grant funded by the MEST.
- Donaldson EF, Lindesmith LC, Lobue AD, Baric RS: Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations. Immunol Rev. 2008, 225: 190-211. 10.1111/j.1600-065X.2008.00680.x.View ArticlePubMedGoogle Scholar
- Yoon JS, Lee SG, Hong SK, Lee SA, Jheong WH, Oh SS, Oh MH, Ko GP, Lee CH, Paik SY: Molecular epidemiology of norovirus infections in children with acute gastroenteritis in South Korea in November 2005 through November 2006. J Clin Microbiol. 2008, 46: 1474-1477. 10.1128/JCM.02282-07.PubMed CentralView ArticlePubMedGoogle Scholar
- Lee YF, Nomoto A, Detjen BM, Wimmer E: A protein covalently linked topoliovirus genome RNA. Proc Natl Acad Sci USA. 1977, 74: 59-63. 10.1073/pnas.74.1.59.PubMed CentralView ArticlePubMedGoogle Scholar
- Rueckert RR, Wimmer E: Systematic nomenclature of picornavirus proteins. J Virol. 1984, 50: 957-959.PubMed CentralPubMedGoogle Scholar
- Tan M, Huang P, Meller J, Zhong W, Farkas T, Jiang X: Mutations within the P2 domain of norovirus capsid affect binding to human histo-blood group antigens: evidence for a binding pocket. J Virol. 2003, 77: 12562-12571. 10.1128/JVI.77.23.12562-12571.2003.PubMed CentralView ArticlePubMedGoogle Scholar
- Nilssson MK, Hedlund O, Thorhagen M, Larson G, Johansen K, Ekspong A, Svensson L: Evolution of human calicivirus RNA in vivo: accumulation of mutations in the protruding P2 domain of the capsid leads to structural changes and possibly a new phenotype. J Virol. 2003, 77: 13117-13124. 10.1128/JVI.77.24.13117-13124.2003.View ArticleGoogle Scholar
- Lochridge VP, Jutila KI, Graff JW, Hardy ME: Epitopes in the P2 domain of norovirus VP1 recognized by monoclonal antibodies that block cell interactions. J Gen Virol. 2005, 86: 2799-2806. 10.1099/vir.0.81134-0.View ArticlePubMedGoogle Scholar
- Glass PJ, White LJ, Bull JM, Leparc-Goffart I, Hardy ME, Estes MK: Norwalk virus open reading frame 3 encodes aminor structural protein. J Virol. 2000, 74: 6581-6591. 10.1128/JVI.74.14.6581-6591.2000.PubMed CentralView ArticlePubMedGoogle Scholar
- Bertolotti-Ciariet A, Crawford SE, Hutson AM, Estes MK: The 3' end of Norwalk virus mRNA contains determinants that regulate the expression and stability of the viral capsid protein VP1: a novel function for the VP2 protein. J Virol. 2003, 77: 11603-11615. 10.1128/JVI.77.21.11603-11615.2003.View ArticleGoogle Scholar
- Kearney K, Menton J, Morgan JG: Carlow virus, a 2002 GII-4 variant norovirus strain from Ireland. Virol J. 2007, 4: 61-10.1186/1743-422X-4-61.PubMed CentralView ArticlePubMedGoogle Scholar
- La Rosa G, Pourshaban M, Iaconelli M, Muscillo M: Detection of genogroup IV noroviruses in environmental and clinical samples and partial sequencing through rapid amplification of cDNA ends. Arch Virol. 2008, 153: 2077-2083. 10.1007/s00705-008-0241-4.View ArticlePubMedGoogle Scholar
- Motomura K, Oka T, Yokoyama M, Nakamura H, Mori H, Ode H, Hansman GS, Katayama K, Kanda T, Tanaka T, Takeda N, Sato H: Identification of monomorphic and divergent haplotypes in the 2006-2007 norovirus GII/4 epidemic population by genome wide tracing of evolutionary history. J Virol. 2008, 82: 11247-11262. 10.1128/JVI.00897-08.PubMed CentralView ArticlePubMedGoogle Scholar
- Hale A, Mattick K, Lewis D, Estes M, Jiang X, Green J, Eglin R, Brown D: Distinct epidemiological patterns of Norwalk-like virus infection. J Med Virol. 2000, 62: 99-103. 10.1002/1096-9071(200009)62:1<99::AID-JMV15>3.0.CO;2-0.View ArticlePubMedGoogle Scholar
- Glass RI, Parashar UD, Estes MK: Norovirus gastroenteritis. N Engl J Med. 2009, 361: 1776-1785. 10.1056/NEJMra0804575.View ArticlePubMedGoogle Scholar
- Lopman B, Vennema H, Kohli E, Pothier P, Sanchez A, Negredo A, Buesa J, Schreier E, Reacher M, Brown D, Gray J, Iturriza M, Gallimore C, Bottiger B, Hedlund KO, Torvén M, von Bonsdorff CH, Maunula L, Poljsak-Prijatelj M, Zimsek J, Reuter G, Szücs G, Melegh B, Svennson L, van Duijnhoven Y, Koopmans M: Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. Lancet. 2004, 363: 682-688. 10.1016/S0140-6736(04)15641-9.View ArticlePubMedGoogle Scholar
- Allen DJ, Noad R, Samuel D, Gray JJ, Roy P, Iturriza-Gómara M: Characterisation of a GII-4 norovirus variant-specific surface-exposed site involved in antibody binding. Virol J. 2009, 6: 150-10.1186/1743-422X-6-150.PubMed CentralView ArticlePubMedGoogle Scholar
- Chung JY, Han TH, Park SH, Kim SW, Hwang ES: Detection of GII-4/2006b Variant and Recombinant Noroviruses in Children With Acute Gastroenteritis, South Korea. J Med Virol. 2010, 82: 146-152. 10.1002/jmv.21650.View ArticlePubMedGoogle Scholar
- Ho EC, Cheng PK, Lau AW, Wong AH, Lim WW: A typical norovirus epidemic in Hong Kong during summer of 2006 caused by a new genogroup II/4 variant. J Clin Microbiol. 2007, 45: 2205-2211. 10.1128/JCM.02489-06.PubMed CentralView ArticlePubMedGoogle Scholar
- Tu ET, Bull RA, Greening GE, Hewitt J, Lyon MJ, Marshall JA, McIver CJ, Rawlinson WD, White PA: Epidemics of gastroenteritis during 2006 were associated with the spread of norovirus GII.4 variants 2006a and 2006b. Clin Infect Dis. 2008, 46: 413-420. 10.1086/525259.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.